1997Research in Experimental MedicineRequires access

Type V phosphodiesterase inhibition modulates endogenous immunoreactivities of endothelin-1 and endothelial nitric oxide synthase in pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension

Takashi Takahashi, Tsugiyasu Kanda, Hiroyuki Sumino, Masahiro Inoue, Kunio Sato, Tetsuo Sakamaki, Isao Kobayashi, Aikichi Iwamoto, Ryozo Nagai

Open publisher page 4 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pulmonary hypertension, Nitric oxide, Endothelin receptor, Nitric oxide synthase, Endothelin 1, Internal medicine, Medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Type V phosphodiesterase inhibition modulates endogenous immunoreactivities of endothelin-1 and endothelial nitric oxide synthase in pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension — Research Paper | ScholarLens